UTX loss alters therapeutic responses in KMT2A-rearranged acute myeloid leukemia

Leukemia. 2023 Jan;37(1):226-230. doi: 10.1038/s41375-022-01741-8. Epub 2022 Oct 29.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Gene Rearrangement
  • Humans
  • Leukemia, Myeloid, Acute* / drug therapy
  • Leukemia, Myeloid, Acute* / genetics
  • Myeloid-Lymphoid Leukemia Protein / genetics

Substances

  • Myeloid-Lymphoid Leukemia Protein